Screener
Charles River Laboratories CRL Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | December 27, 2025 |
|---|---|---|
| Finance leases | 9,848 | 27,876 |
| Total debt and finance leases | 2,637,381 | 2,152,221 |
| Less: | ||
| Current portion of long-term debt | 5,460 | 166 |
| Current portion of finance leases | 1,166 | 3,228 |
| Current portion of long-term debt and finance leases | 6,626 | 3,394 |
| Long-term debt and finance leases | 2,630,755 | 2,148,827 |
| Debt discount and debt issuance costs | (10,770) | (12,467) |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's current debt?
- Charles River Laboratories (CRL) reported current debt of $5.46M in Q2 2026.
- How has Charles River Laboratories's current debt changed year-over-year?
- Charles River Laboratories's current debt increased by 5471.4% year-over-year, from $98K to $5.46M.
- What is the long-term trend for Charles River Laboratories's current debt?
- Over 5 years (2020 to 2025), Charles River Laboratories's current debt has grown at a -67.7% compound annual growth rate (CAGR), from $47.2M to $166K.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Charles River Laboratories's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude